Luminary Therapeutics

Minneapolis, MN · Founded 2019 · Privately Held (backing)

Developer a cell therapy platform designed for cancer and autoimmune diseases. Luminary Therapeutics is based in Minneapolis, MN and was founded in 2019. Its last reported valuation was $59 million in Apr 2025. It has raised $24.2 million across 6 recorded rounds; the latest was a $1.4 million seed round in Oct 2025.

Last reported valuation
$59.0M
Oct 2026
Priced at
—
Total raised
$24.2M
Last round
Seed Round
Oct 2025
What is Luminary Therapeutics worth?
$59.0Mlast reported valuation · Oct 2026

Luminary Therapeutics's last reported valuation, Apr 2025. Nothing priced has surfaced since.

Free account
More of Luminary Therapeutics with a free account
  • ·Watch Luminary Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Luminary Therapeutics funding history

6 rounds
DateRoundRaisedPost-money
Oct 2025Seed Round$1.4M▮
Nov 2024Early Stage VC$5.2M▮
Sep 2022Early Stage VC$5.2M▮
Oct 2021Seed Round$375K▮
Jan 2021Seed Round$825K▮
Oct 2019Seed Round$1.5M▮
Unlock post-money valuations

Membership and data by Private Market View

Luminary Therapeutics valuation

Luminary Therapeutics's last reported valuation was $59 million in Apr 2025. No priced round, secondary trade or fund mark has surfaced since.

How much has Luminary Therapeutics raised?

Luminary Therapeutics has raised $24.2 million across 6 recorded rounds since 2019. The largest was an $825,000 seed round in Jan 2021; the most recent was a $1.4 million seed round in Oct 2025.

Luminary Therapeutics has filed 7 Form Ds with the SEC since 2019, most recently in Jan 2025 ($5.2 million sold to 49 investors).

How Luminary Therapeutics's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Luminary Therapeutics, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by last reported valuation. Question about this number? Full methodology →

Frequently asked about Luminary Therapeutics

What is Luminary Therapeutics worth?
Luminary Therapeutics is valued at $59.0M as of Oct 2026. Luminary Therapeutics's last reported valuation, Apr 2025. Nothing priced has surfaced since.
How much has Luminary Therapeutics raised?
Luminary Therapeutics has raised $24.2M in total funding across 6 recorded rounds.
When did Luminary Therapeutics last raise?
Luminary Therapeutics last raised in Oct 2025 (Seed Round), raising $1.4M.